Stroke Clinical Trials – DEFUSE 3 & DAWN Trials

preview_player
Показать описание
Akash Kansagra, MD, Washington University neurointerventional surgeon at Barnes-Jewish Hospital, talks about the latest clinical trials and advances in technology for treating stroke. The DEFUSE 3 and DAWN trials have expanded the time window for effectively treating stroke patients from just 6 hours after symptoms start to 24 hours. This results in better outcomes and can help patients live a normal life after having a stroke.

Connect with Barnes-Jewish Hospital:
Рекомендации по теме
welcome to shbcf.ru